Keywords
Vaccine coverage
Epidemiology
Diphtheria-Tetanus-a cellular Pertussis vaccine
Vaccination
How to Cite
Abstract
Pertussis is currently considered an important public heath problem in developed countries. Besides high vaccine coverage, a raise in incidence coefficients (a coefficient of incidence raise) for all age groups has been observed. This epidemiological situation demands new epidemiological strategies, like, for example, the use of a cellular vaccine in adolescents and young adults. At the same time, in Brazil, there is no evidence of whooping cough recrudescence, even because the introduction of massive immunization happened very recently in this country as compared to the developed ones. The present work is a descriptive study of whooping cough epidemiological situation during (in) the past seven years (1999-2005), based on suspected and confirmed cases notified by cities located within the Regional Health Department of DIR XV - Piracicaba.
References
Secretaria de Estado da Saúde de São Paulo. Centro de Vigilância Epidemiológica “Prof. Alexandre Vranjac”. Manual de Vigilância Epidemiológica. Coqueluche Normas e Instruções. São Paulo; 2001.
Puccini RF, Junqueira EMJ, Farhal CK. Epidemiologia das Doenças Imunopreveníveis no Brasil. In: Bricks LF, Cervi MC. Atualidades em doenças infecciosas - Manejo e prevenção: série atualizações pediátricas. Sociedade de Pediatria de São Paulo. Ed.: Atheneu; 2002.
Luz PM, Codeço CT, Werneck GL. A Reemergência da coqueluche em países desenvolvidos: um problema também para o Brasil? Cad. de Saúde Pública 2003.19 (4):1209-1213.
World Health Organization (WHO). Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases. 15 February, 2002.
Campis-Martin M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, Mertsola J, Oselka G, Ward J, Wirsing-Von-Konig CH, Zepp F. Recommendations are needed for adolescent and adult pertussis immunization: Rationale and strategies for consideration. Vaccine 2001; 20:641-646.
Ivanoff B, Robertson SE. Pertussis Vacine Trials. Pertussis: a worldwide problem. Developments in Biological Standardization 1997; 83:3-13.
Bass JW, Wittler RR. Return of epidemic pertussis in United States. Pediatr Infect Dis J. 1994;13:343.
Mortimer EA. Pertussis and its prevention: a family affair. Infect Dis J. 1990; 161:473.
Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States, 1980-1989. Clinical Infectious Diseases 1992. 14:708-719.
Savage JV, Decker MD, Edwards K et al. Natural history of pertussis antibody in the infant and effect on vaccine response. Infect Dis J. 1990;161:487.
Edmunds WJ, Brisson M, Malegaro A. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine 2002; 20:1316-1330.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2006 Alexandre dos Santos Martins, Glaucia Elisa Cruz Perecin, Lucelena de Fátima Octaviano Noale